Hi
A medical device (denture repairing system) composed of 3 separate components; during clinical use 1 Component is applied on the denture; after curing, 2 other components are mixed by the user and applied on this denture; my question : do you think that cytotoxicity of the MD (denture repairing system) should be evaluated separetely of each of 3 components or we have to test cytotoxicity of the mix of the 3 components ?
Thanks in advance for your support
A medical device (denture repairing system) composed of 3 separate components; during clinical use 1 Component is applied on the denture; after curing, 2 other components are mixed by the user and applied on this denture; my question : do you think that cytotoxicity of the MD (denture repairing system) should be evaluated separetely of each of 3 components or we have to test cytotoxicity of the mix of the 3 components ?
Thanks in advance for your support